For more than four decades, Lilly Oncology has been dedicated to delivering innovative solutions that improve the care of people living with cancer. Our quest is to develop a broad portfolio of tailored therapies that accelerate the pace and progress of cancer care. To learn more about Lilly Oncology's commitment to cancer, please visit www.LillyOncology.com.
Content provided by this sponsor:
Industry Satellite Symposia from ELCC 2016
The Springer Healthcare IME symposium: Navigating the advanced NSCLC patient pathway: new markers and targets was funded by an independent educational grant from Eli Lilly and Company